• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Substance Abuse Treatment, Prevention, and Policy >Naloxone availability in independent community pharmacies in Georgia, 2019
【24h】

Naloxone availability in independent community pharmacies in Georgia, 2019

机译：纳洛酮在2019年格鲁吉亚的独立社区药房的可用性

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Increasing the availability of naloxone among people who use opioids, and friends and family of past and present people who use opioids is a vitally important mission to reduce the occurrence of opioid-related overdose deaths. The purpose of this study was to determine the availability of naloxone in independent community pharmacies in Georgia. Secondary objectives include determining pharmacists’ knowledge regarding the standing order and ability to counsel regarding naloxone. A cross-sectional study using a secret shopper approach with phone contact was conducted over a period of 10 months. The study was population based and was conducted at all independent pharmacies in the state of Georgia. All independent community pharmacies in the state of Georgia were contacted and asked the naloxone questions with a 96% response rate (n?=?520). Five hundred fifty-eight independent community pharmacies were called, with a 96% response rate (n?=?520 pharmacies). Two hundred-twenty pharmacies reported having naloxone in stock. Of the 335 pharmacists asked, 174 (51.9%) incorrectly said that a prescription was required. The mean (SD) cash price was $148.02 (27.40), with a range of $0 to $300. Of 237 pharmacists asked who had naloxone in stock or who stated they could get naloxone in stock, 212 stated that they could demonstrate how to use it, 8 stated they could not, and 17 said that they possibly could or were unsure how to use it. This study provided insight into the limited availability of naloxone at independent community pharmacies in Georgia after the standing order was issued. The majority of pharmacists at independent pharmacies in Georgia were not using the publicly available state naloxone standing order. Additionally, the low availability of naloxone and its high cost for uninsured individuals are significant structural barriers for reducing opioid-related mortality.
机译：增加使用阿片类药物和过去和目前使用阿片类药物的人的人的纳洛酮的可用性是一种最重要的使命，可以减少与阿片类药物相关的过量死亡的发生。本研究的目的是确定格鲁吉亚独立社区药房中纳洛酮的可用性。次要目标包括确定药剂师对常规秩序的知识和关于纳洛酮的律师的能力。使用带有电话联系的秘密购物者方法的横断面研究在10个月内进行。该研究是基于人口，并在格鲁吉亚州的所有独立药房进行。联系了格鲁吉亚州的所有独立社区药房，并以96％的响应率提出了纳洛酮问题（n？= 520）。称为五百五十八个独立社区药店，响应率为96％（n？= 520药房）。有两种二十个药房报道纳洛酮有库存。在335名药剂师询问，174名（51.9％）错误地说，需要处方。平均值（SD）现金价格为148.02美元（27.40），范围为0至300美元。 237家的药剂师们曾经有牛油尼牛油纳或者谁可以获得纳尔诺酮库存，212表示他们可以证明如何使用它，8表示他们不能，17说他们可能会或不确定如何使用它。本研究提供了在常规订单发布后格鲁吉亚独立社区药房的有限可用性的洞察力。格鲁吉亚独立药房的大多数药剂师都没有使用公开的国家纳洛酮常规订单。另外，纳洛酮的低可用性及其对未经保险的个体的高成本是降低阿片类药物相关死亡率的显着结构障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号